Mp21-05 Temporal Trends in Prostate Cancer Risk Group Stratification Following the 2008 United States Preventive Services Task Force Recommendations
Year: 2016
Type: article
Abstract: ESBL in 2.2%.15% of patients who were not swabbed received i.v antibiotics.6/808 (0.7%) screened patients developed sepsis, as opposed to 4/124 (3.2%) in patients not screened (p¼0.03Fischer's exact test).Allowing for all costs incurred by screening, including intravenous antibiotics, screening for FRE saved $10/patient biopsied.CONCLUSIONS: Screening for fluoroquinolone resistant E. coli prior to TRUS guided prostate biopsy with subsequent targeted antibiotics is a cost effective strategy to significantly reduce the risk of post biopsy sepsis.
Source: The Journal of Urology
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2986970137
